pentosidine has been researched along with Bone Diseases, Metabolic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marumo, K; Saito, M | 1 |
| Suzuki, A | 1 |
2 review(s) available for pentosidine and Bone Diseases, Metabolic
| Article | Year |
|---|---|
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone quality in chronic kidney disease : enzymatic and non-enzymatic glycation or oxidation induced cross-links in bone].
Topics: Animals; Arginine; Bone and Bones; Bone Diseases, Metabolic; Chronic Disease; Collagen; Fractures, Bone; Glycation End Products, Advanced; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Lysine; Osteoporosis; Oxidative Stress; Risk | 2010 |
[Is bone biopsy necessary for the diagnosis of metabolic bone diseases? Non- invasive assessment of bone turn over markers could define the cause of metabolic bone diseases].
Topics: Acid Phosphatase; Alkaline Phosphatase; Arginine; Biomarkers; Biopsy; Bone and Bones; Bone Diseases, Metabolic; Collagen Type I; Diagnosis, Differential; Homocysteine; Humans; Isoenzymes; Lysine; Osteoporosis; Peptide Fragments; Peptides; Procollagen; Tartrate-Resistant Acid Phosphatase | 2011 |